SLC5A1 and type 2 diabetes mellitus: Hyperinsulinemia-mediated increases in SGLT1 expression are relevant in type 2 diabetes because, despite generalized insulin resistance, hyperinsulinemia is associated with ERK activation through the IGF-1 receptor [43].